Here we go again.
After everything New Zealand's infant formula industry has been through over the past few years, the last thing it needed was yesterday's news of the 1080 threat.
Formula exporters are still recovering from the impact of Fonterra's 2013 botulism scare, which spooked consumers in China, the main market for product manufactured in this country.
And then there's the challenges posed by tough new Chinese import regulations that came into force last May and put many companies out of business.
New Zealand infant formula exports to China almost doubled to $200 million between 2012-2013, but are understood to have more than halved since then.